Press "Enter" to skip to content

New patent expiration for United Therap drug REMODULIN

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for United Therap drug REMODULIN

Annual Drug Patent Expirations for REMODULIN
Annual Drug Patent Expirations for REMODULIN

Remodulin is a drug marketed by United Therap
and is included in one NDA. It is available from one supplier. There are nine patents protecting this drug and two Paragraph IV challenges.

This drug has fifty-five patent family members in twelve countries.

The generic ingredient in REMODULIN is treprostinil. One supplier is listed for this compound. Additional details are available on the treprostinil profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,
contact admin@DrugPatentWatch.com
or visit www.DrugPatentWatch.com

Copyright © DrugPatentWatch. Originally published at New patent expiration for United Therap drug REMODULIN
Do NOT follow this link or you will be banned from the site!